Principal Investigator
Henry Moore
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251400
Clinical Trial Summary
A randomized, placebo-controlled, double-blind Phase 3
study to evaluate the efficacy, safety, and tolerability of
Votoplam in participants with Huntington’s Disease
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Wilfredo Rodriguez Somoza
Phone Number
+1 (561) 9394169
Email
wxr205@miami.edu